Modulation of MK-801 response by dopaminergic agents in mice

Psychopharmacology

Volumn 107, Issue 2-3, 1992, Pages 431-436

  Verma, Anita ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apomorphine; Dopamine; Ketamine; MK 801; SKF 38393; Stereotypy

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CLOZAPINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; HALOPERIDOL; KETAMINE; METIROSINE; MOLINDONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RESERPINE; TALIPEXOLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

ANIMAL; DIZOCILPINE MALEATE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KETAMINE; MALE; MICE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RESERPINE; STEREOTYPED BEHAVIOR; SUPPORT, NON-U.S. GOV'T; SYNAPTIC TRANSMISSION;

EID: 0026539326     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02245171     Document Type: Article

References (34)

1. Demonstration and mapping out of nigroneostriatal dopamine neurons
2. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl- d-aspartate
3. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
4. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice
5. Central sympathomimetic activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo(a,d) cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties
6. Characterization of l-glutamate action on the release of endogenous dopamine from the rat caudate-putamen
7. On the mode of action of apomorphine
8. Inhibitory effects of noradrenaline and dopamine on calcium influx and neurotransmitter glutamate release in mammalian brain slices
9. Glutamatergic pathways in the pigeon and rat brain
10. Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic cell bodies in the rat
11. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response
12. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine
13. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
14. Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxy-dopamine-induced lesions of the substantia nigra
15. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system
16. Comparison of the behavioural and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
17. The emetic effect of B-HT 920 and apomorphine in dogs: antagonism by haloperidol
18. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
19. Negative symptomatology and the PCP (phencyclidine) model of schizophrenia
20. Effect of the NMDA receptor antagonist, MK-801 on locomotor activity and on the metabolism of dopamine in various brain areas of mice
21. Release regulating D2 dopamine receptors located on striatal glutamatergic nerve terminals
22. Role of N-methyl- d-aspartate (NMDA) receptors in experimental catalepsy in rats
23. Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs
24. MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxy dopamine model of Parkinson's disease
25. Striatal glutamatergic function: modifications following specific lesions
26. Brain dopamine receptors
27. The central effects of a novel dopamine agonist
28. Antagonism of N-methyl- d-aspartate induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behaviour
29. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA- induced norepinephrine release
30. Phencyclidine
31. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice
32. Sigma receptors: biology and function
33. Specific [3H]-phencyclidine binding in rat central nervous system